Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

An2 Therapeutics, Inc. (ANTX) AI Forecast

Our AI analyzed An2 Therapeutics, Inc.. Create a free account to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$ANTX Neutral Signal Full forecast available
Sign Up Free

An2 Therapeutics, Inc. (ANTX) Stock Forecast 2025

An2 Therapeutics, Inc. (ANTX) AI Stock Price Forecast & Investment Analysis

An2 Therapeutics, Inc. Stock Price Chart and Technical Analysis

Loading chart...

An2 Therapeutics, Inc. (ANTX) - Comprehensive Stock Analysis & Investment Research

Deep dive into An2 Therapeutics, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on April 15, 2026, 3:10 p.m. (UTC)

An2 Therapeutics, Inc. Investment Summary

When evaluating whether An2 Therapeutics, Inc. (ANTX) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

An2 Therapeutics, Inc. (ANTX) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $107 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers An2 Therapeutics, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for An2 Therapeutics, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether An2 Therapeutics, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for An2 Therapeutics, Inc.

Sign Up Free
Corporate Identity

An2 Therapeutics, Inc. (Stock Symbol: ANTX) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about An2 Therapeutics, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for An2 Therapeutics, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for An2 Therapeutics, Inc....

Unlock Full Company Profile

Get complete details about An2 Therapeutics, Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for An2 Therapeutics, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for An2 Therapeutics, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for An2 Therapeutics, Inc....

Unlock Financial Analysis

Get complete financial metrics for An2 Therapeutics, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock An2 Therapeutics, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

An2 Therapeutics, Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

An2 Therapeutics, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

An2 Therapeutics, Inc. (ANTX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for An2 Therapeutics, Inc. stock analysis.

Deep dive into An2 Therapeutics, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if An2 Therapeutics, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For An2 Therapeutics, Inc.:

P/B Ratio 2.02x
Market Cap $107M
Book Value/Share $1.48
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently An2 Therapeutics, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For An2 Therapeutics, Inc.: An ROE of -57.7% indicates room for improvement in shareholder value creation.

ROE -57.7%
ROA -49.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess An2 Therapeutics, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For An2 Therapeutics, Inc.:

D/E Ratio 0.17x
Financial Leverage 1.17x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal An2 Therapeutics, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For An2 Therapeutics, Inc.:

Operating Cash Flow -$27M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively An2 Therapeutics, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For An2 Therapeutics, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from An2 Therapeutics, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For An2 Therapeutics, Inc.:

Income Statement
Operating Income -$30M
Net Income -$30M
R&D Expense $23M
Balance Sheet Highlights (% Of Assets)
Total Liabilities 9%
Dividend & Shareholder Information
Shares Outstanding 36M

Latest An2 Therapeutics, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting An2 Therapeutics, Inc. (ANTX) stock price and investment outlook.

More news available

Sign up free to read all 8 news articles and stay updated on market developments.

Sign Up Free to Read More

An2 Therapeutics, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of An2 Therapeutics, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $101M x 1.0x
Abbvie Inc. ABBV ██% $372.07B 88.0x x
Abcellera Biologics Inc. ABCL ██% $1.13B x 1.2x
Abeona Therapeutics Inc. ABEO ██% $286M 4.0x 1.8x
Abbott Laboratories ABT ██% $175.93B 27.0x 3.4x
Arbutus Biopharma Corp ABUS ██% $838M x 10.9x
Abvc Biopharma, Inc. ABVC ██% $34M x 3.1x
Abivax S.A. ABVX ██% $9.88B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.75B 9.6x 3.1x
Adicet Bio, Inc. ACET ██% $67M x 0.4x
Aclaris Therapeutics, Inc. ACRS ██% $472M x 4.6x
Acrivon Therapeutics, Inc. ACRV ██% $64M x 0.6x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $6M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $8M x 1.5x
Adagene Inc. ADAG ██% $252M x 6.6x
Adc Therapeutics Sa ADCT ██% $485M x x
Adial Pharmaceuticals, Inc. ADIL ██% $2M x 0.4x
Aditxt, Inc. ADTX ██% $380K x 0.1x
Addex Therapeutics Ltd. ADXN ██% $9M x x
Aeon Biopharma, Inc. AEON ██% $22M x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.95B x 1.6x
Ainos, Inc. AIMD ██% $12M x 1.6x
Akebia Therapeutics, Inc. AKBA ██% $414M x 12.7x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $5M x 0.2x
Aldeyra Therapeutics, Inc. ALDX ██% $108M x 2.4x
Alkermes Plc. ALKS ██% $5.61B 23.2x 3.1x
Allarity Therapeutics, Inc. ALLR ██% $19M x 2.0x
Alumis Inc. ALMS ██% $2.91B x 9.7x
Alnylam Pharmaceuticals, Inc. ALNY ██% $44.93B 143.2x 56.9x
Altimmune, Inc. ALT ██% $428M x 1.9x
Alx Oncology Holdings Inc ALXO ██% $213M x 8.2x
Alzamend Neuro, Inc. ALZN ██% $4M x 1.8x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.86B x 6.1x
Amphastar Pharmaceuticals, Inc. AMPH ██% $976M 10.0x 1.2x
Amarin Corp Plc\Uk AMRN ██% $305M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $4.11B 57.1x x
Anaptysbio, Inc ANAB ██% $1.97B x 52.9x
Anebulo Pharmaceuticals, Inc. ANEB ██% $21M x 2.6x
Ani Pharmaceuticals Inc ANIP ██% $1.76B 22.5x 3.3x
Anixa Biosciences Inc ANIX ██% $96M x 6.4x
Annexon, Inc. ANNX ██% $866M x 4.1x
Alto Neuroscience, Inc. ANRO ██% $824M x 5.5x
An2 Therapeutics, Inc. ANTX ██% $107M x 2.0x
Annovis Bio, Inc. ANVS ██% $47M x 2.8x
Apollomics Inc. APLM ██% $33M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.17B 231.0x 14.0x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $11M x 0.9x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $24M x 2.9x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.3x
Aquestive Therapeutics, Inc. AQST ██% $506M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $247M x 1.2x
Ardelyx, Inc. ARDX ██% $1.55B x 9.3x
Arcutis Biotherapeutics, Inc. ARQT ██% $3.09B x 16.3x
Artelo Biosciences, Inc. ARTL ██% $4M x x
Arvinas, Inc. ARVN ██% $698M x 1.6x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $9.16B 45.3x 16.1x
Aspire Biopharma Holdings, Inc. ASBP ██% $6M x x
Assembly Biosciences, Inc. ASMB ██% $467M x 2.3x
Ascendis Pharma A/S ASND ██% $15.48B x x
Assertio Holdings, Inc. ASRT ██% $116M x 1.2x
Atai Beckley N.V. ATAI ██% $1.40B x 8.8x
Alterity Therapeutics Ltd ATHE ██% $68M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $34M x 4.4x
Atossa Therapeutics, Inc. ATOS ██% $46M x 1.2x
Avenue Therapeutics, Inc. ATXI ██% $2M x 0.9x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.13B 7.4x 3.7x
Arrivent Biopharma, Inc. AVBP ██% $1.17B x 3.8x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $453M x 1.7x
Avalo Therapeutics, Inc. AVTX ██% $317M x 3.8x
Axim Biotechnologies, Inc. AXIM ██% $2M x x
Axsome Therapeutics, Inc. AXSM ██% $9.37B x 106.1x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $4M x 0.9x
Bridgebio Pharma, Inc. BBIO ██% $15.18B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $734M x 1.8x
Bicara Therapeutics Inc. BCAX ██% $1.50B x 3.8x
Briacell Therapeutics Corp. BCTX ██% $33M x 1.1x
Bicycle Therapeutics Plc BCYC ██% $351M x 0.6x
Bioadaptives, Inc. BDPT ██% $130K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $19M x 8.7x
Biofrontera Inc. BFRI ██% $13M x 1.2x
Bio Green Med Solution, Inc. BGMS ██% $6M x 0.8x
Bausch Health Companies Inc. BHC ██% $2.10B 13.4x x
Bioharvest Sciences Inc. BHST ██% $97M x 3.8x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $735M x 2.7x
Bio Essence Corp BIOE ██% $15M 17.0x x
Biovie Inc. BIVI ██% $11M x 0.6x
Bioxytran, Inc BIXT ██% $4M x x
Biolinerx Ltd. BLRX ██% $11M x x
Belite Bio, Inc BLTE ██% $6.76B x 8.8x
Biomea Fusion, Inc. BMEA ██% $141M x 4.8x
Biomarin Pharmaceutical Inc BMRN ██% $10.67B 30.6x 1.8x
Bristol Myers Squibb Co BMY ██% $118.13B 16.8x 6.4x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $454M x 2.4x
Boundless Bio, Inc. BOLD ██% $35M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $9M x 0.3x
Bio-Path Holdings, Inc. BPTH ██% $480K x x
Bioquest Corp BQST ██% $14M x x
Barinthus Biotherapeutics Plc. BRNS ██% $25M x 0.3x
Bespoke Extracts, Inc. BSPK ██% $2M x x
Bioxcel Therapeutics, Inc. BTAI ██% $29M x x
Beyondspring Inc. BYSI ██% $70M x x
Calcimedica, Inc. CALC ██% $10M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.3x
Capricor Therapeutics, Inc. CAPR ██% $1.99B x 6.5x
Carisma Therapeutics Inc. CARM ██% $1M 0.2x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $484M x 2.3x
Gyre Therapeutics, Inc. CBIO ██% $594M 60.2x 5.6x
Cdt Equity Inc. CDT ██% $23M x 5.3x
Cingulate Inc. CING ██% $62M x 24.8x
Cell Source, Inc. CLCS ██% $40M x x
Clene Inc. CLNN ██% $72M x x
Cellectar Biosciences, Inc. CLRB ██% $13M x 1.5x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $1M x x
Climb Bio, Inc. CLYM ██% $603M x 3.8x
Chemomab Therapeutics Ltd. CMMB ██% $12M x 1.0x
Clearmind Medicine Inc. CMND ██% $2M x x
Compass Pathways Plc CMPS ██% $741M x x
Cnbx Pharmaceuticals Inc. CNBX ██% $170K x x
Cns Pharmaceuticals, Inc. CNSP ██% $2M x 0.5x
Centessa Pharmaceuticals Plc CNTA ██% $5.91B x 11.2x
Connect Biopharma Holdings Ltd CNTB ██% $172M x 4.1x
Canton Strategic Holdings, Inc. CNTN ██% $192M x 0.5x
Context Therapeutics Inc. CNTX ██% $231M x 3.8x
Cocrystal Pharma, Inc. COCP ██% $21M x 3.3x
Cogent Biosciences, Inc. COGT ██% $5.87B x 9.2x
Collegium Pharmaceutical, Inc COLL ██% $1.13B 18.0x 3.8x
Corcept Therapeutics Inc CORT ██% $4.63B 46.5x 7.1x
Coya Therapeutics, Inc. COYA ██% $105M x 2.4x
China Pharma Holdings, Inc. CPHI ██% $25M x 3.0x
Cumberland Pharmaceuticals Inc CPIX ██% $48M x 1.9x
Cannapharmarx, Inc. CPMD ██% $3M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.21B 15.0x 3.4x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $176M x 1.2x
Cormedix Inc. CRMD ██% $579M 3.6x 1.4x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.80B x 3.8x
Cervomed Inc. CRVO ██% $37M x 2.1x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.28B x 20.9x
Cytomx Therapeutics, Inc. CTMX ██% $981M x 9.9x
Contineum Therapeutics, Inc. CTNM ██% $484M x 1.9x
Citius Oncology, Inc. CTOR ██% $66M x 1.1x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Citius Pharmaceuticals, Inc. CTXR ██% $18M x 0.2x
Cue Biopharma, Inc. CUE ██% $42M x 1.6x
Curanex Pharmaceuticals Inc CURX ██% $13M x 1.2x
Cadrenal Therapeutics, Inc. CVKD ██% $11M x 4.1x
Cv Sciences, Inc. CVSI ██% $6M x 3.9x
Cyclerion Therapeutics, Inc. CYCN ██% $14M x 1.5x
Cytodyn Inc. CYDY ██% $452M x x
Cypherpunk Technologies Inc. CYPH ██% $80M 16.5x 0.5x
Cryoport, Inc. CYRX ██% $496M 6.3x 1.0x
Cytokinetics Inc CYTK ██% $8.17B x x
Dare Bioscience, Inc. DARE ██% $25M x 8.9x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.21B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $3M x 0.6x
Journey Medical Corp DERM ██% $175M x 5.5x
Diamedica Therapeutics Inc. DMAC ██% $351M x 6.3x
Damora Therapeutics, Inc. DMRA ██% $1.61B x 6.7x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $5.17B x 10.5x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $872M x x
Design Therapeutics, Inc. DSGN ██% $763M x 3.6x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $60M x 0.8x
Dyne Therapeutics, Inc. DYN ██% $3.27B x 3.4x
Emergent Biosolutions Inc. EBS ██% $451M 8.6x 0.9x
Edesa Biotech, Inc. EDSA ██% $44M x 3.1x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $8M x 1.1x
Elanco Animal Health Inc ELAN ██% $11.98B x 1.8x
Eledon Pharmaceuticals, Inc. ELDN ██% $241M x 3.0x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $408M 14.9x 5.1x
Elicio Therapeutics, Inc. ELTX ██% $209M x 127.6x
Enliven Therapeutics, Inc. ELVN ██% $2.67B x 5.8x
Emmaus Life Sciences, Inc. EMMA ██% $700K x x
Enlivex Ltd. ENLV ██% $195M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $5M x 1.5x
Enanta Pharmaceuticals Inc ENTA ██% $425M x 3.4x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $4M x 0.9x
Evolus, Inc. EOLS ██% $289M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $444M x 5.4x
Equillium, Inc. EQ ██% $118M x 4.1x
Erasca, Inc. ERAS ██% $5.07B x 15.6x
Ernexa Therapeutics Inc. ERNA ██% $6M x 2.5x
Esperion Therapeutics, Inc. ESPR ██% $526M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $734M x 28.1x
Earth Science Tech, Inc. ETST ██% $35M 8.5x 6.1x
Evofem Biosciences, Inc. EVFM ██% $1M 2.8x x
Evommune, Inc. EVMN ██% $959M x 4.7x
Edgewise Therapeutics, Inc. EWTX ██% $3.52B x 6.8x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $76M 11.1x 1.5x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $6M x 1.0x
Forte Biosciences, Inc. FBRX ██% $635M x 10.4x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $275M x x
Filana Therapeutics, Inc. FLNA ██% $77M x 1.0x
Amicus Therapeutics, Inc. FOLD ██% $4.49B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $526M x 1.5x
Galectin Therapeutics Inc GALT ██% $161M x x
Gain Therapeutics, Inc. GANX ██% $80M x 4.3x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $200K x x
Cytomed Therapeutics Ltd GDTC ██% $12M x x
Geron Corp GERN ██% $1.13B x 5.0x
Gh Research Plc GHRS ██% $1.04B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $5M x 0.3x
Galapagos Nv GLPG ██% $1.90B x x
Greenwich Lifesciences, Inc. GLSI ██% $359M x 164.3x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $118M x 10.3x
Genprex, Inc. GNPX ██% $11M x 1.4x
Gossamer Bio, Inc. GOSS ██% $101M x x
Geovax Labs, Inc. GOVX ██% $3M x 0.6x
Structure Therapeutics Inc. GPCR ██% $3.77B x 2.5x
Grace Therapeutics, Inc. GRCE ██% $66M x 1.0x
Gridai Technologies Corp. GRDX ██% $7M x 0.3x
Gri Bio, Inc. GRI ██% $4M x 0.6x
Galera Therapeutics, Inc. GRTX ██% $13M 0.1x 3.2x
Gsk Plc GSK ██% $118.21B x x
Gt Biopharma, Inc. GTBP ██% $12M x 2.1x
Gyre Therapeutics, Inc. GYRE ██% $716M 72.5x 6.8x
Hutchmed (China) Ltd HCM ██% $2.62B 2.9x 2.1x
Hcw Biologics Inc. HCWB ██% $2M x 0.8x
Cybin Inc. HELP ██% $272M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $560K x 0.2x
Vyome Holdings, Inc HIND ██% $16M x 6.6x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $14M x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $12M x 2.0x
Werewolf Therapeutics, Inc. HOWL ██% $45M x 1.8x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.69B 10.7x 1.9x
Heron Therapeutics, Inc. /De/ HRTX ██% $177M x 12.4x
Hst Global, Inc. HSTC ██% $9M x 7.2x
Tuhura Biosciences, Inc./Nv HURA ██% $187M x 8.9x
Mindwalk Holdings Corp. HYFT ██% $55M x x
Hyperion Defi, Inc. HYPD ██% $41M x 1.0x
Ibio, Inc. IBIO ██% $76M x 1.3x
Impact Biomedical Inc. IBO ██% $71M x 5.7x
Ideaya Biosciences, Inc. IDYA ██% $2.84B x 2.8x
Inflarx N.V. IFRX ██% $82M x x
Igc Pharma, Inc. IGC ██% $29M x 4.0x
Immutep Ltd IMMP ██% $46M x x
Immix Biopharma, Inc. IMMX ██% $522M x 5.6x
Immunome Inc. IMNM ██% $2.59B x 4.1x
Imunon, Inc. IMNN ██% $12M x 1.7x
Immuron Ltd IMRN ██% $9M x x
Immuneering Corp IMRX ██% $350M x 1.6x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $154M x x
Integrated Biopharma Inc INBP ██% $9M x 0.4x
Indaptus Therapeutics, Inc. INDP ██% $5M x 1.6x
Indivior Pharmaceuticals, Inc. INDV ██% $4.12B 19.6x x
Inmed Pharmaceuticals Inc. INM ██% $2M x 0.3x
Inovio Pharmaceuticals, Inc. INO ██% $91M x 3.8x
Insmed Inc INSM ██% $32.87B x 44.5x
Inhibitor Therapeutics, Inc. INTI ██% $13M x x
Innoviva, Inc. INVA ██% $1.79B 6.6x 1.5x
Io Biotech, Inc. IOBT ██% $550K x 0.6x
Ionis Pharmaceuticals Inc IONS ██% $12.54B x 25.6x
Opus Genetics, Inc. IRD ██% $388M x 25.3x
Disc Medicine, Inc. IRON ██% $2.67B x 3.6x
Ironwood Pharmaceuticals Inc IRWD ██% $659M 27.4x x
International Stem Cell Corp ISCO ██% $1M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $1.14B x x
Incannex Healthcare Inc. IXHL ██% $49M x 0.7x
Jaguar Health, Inc. JAGX ██% $5M x 0.9x
Janux Therapeutics, Inc. JANX ██% $920M x 1.0x
Jazz Pharmaceuticals Plc JAZZ ██% $12.35B x 2.9x
Jade Biosciences, Inc. JBIO ██% $959M x 2.9x
Johnson & Johnson JNJ ██% $578.02B 21.6x 7.1x
Jupiter Neurosciences, Inc. JUNS ██% $14M x 249.0x
Kala Bio, Inc. KALA ██% $206M x x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.03B x x
Kairos Pharma, Ltd. KAPA ██% $12M x 2.0x
Kaya Holdings, Inc. KAYS ██% $22M x x
Kamada Ltd KMDA ██% $486M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.48B 59.0x 6.1x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $75M x x
Keros Therapeutics, Inc. KROS ██% $226M 2.6x 0.7x
Korro Bio, Inc. KRRO ██% $131M x 2.6x
Pasithea Therapeutics Corp. KTTA ██% $18M x 0.3x
Kura Oncology, Inc. KURA ██% $803M x 4.6x
Kyntra Bio, Inc. KYNB ██% $30M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $672M x 2.2x
Legend Biotech Corp LEGN ██% $6.91B x x
Lexaria Bioscience Corp. LEXX ██% $25M x 3.9x
Lifecore Biomedical, Inc. \De\ LFCR ██% $195M x x
Lifevantage Corp LFVN ██% $53M 6.7x 1.6x
Ligand Pharmaceuticals Inc LGND ██% $4.59B 36.9x 4.5x
Longeveron Inc. LGVN ██% $33M x 5.8x
Lianbio LIANY ██% $13M x 0.1x
Lftd Partners Inc. LIFD ██% $4M 44.6x 0.1x
Lipella Pharmaceuticals Inc. LIPO ██% $100K x 0.1x
Lite Strategy, Inc. LITS ██% $43M x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $14M x 1.5x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Eli Lilly & Co LLY ██% $827.76B 40.1x 31.2x
Lunai Bioworks Inc. LNAI ██% $8M 5.1x x
Lipocine Inc. LPCN ██% $18M x 1.3x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $3.38B x 75.4x
Larimar Therapeutics, Inc. LRMR ██% $405M x 5.2x
Lisata Therapeutics, Inc. LSTA ██% $40M x 2.7x
Lantern Pharma Inc. LTRN ██% $26M x 4.0x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $741M x 6.9x
Lyell Immunopharma, Inc. LYEL ██% $497M x 2.0x
Maia Biotechnology, Inc. MAIA ██% $83M x 35.0x
Mustang Bio, Inc. MBIO ██% $6M x 0.6x
Moleculin Biotech, Inc. MBRX ██% $13M x 0.9x
Mbx Biosciences, Inc. MBX ██% $1.47B x 4.0x
Seres Therapeutics, Inc. MCRB ██% $82M 14.5x 1.9x
Medicus Pharma Ltd. MDCX ██% $16M x x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $11.99B x 19.9x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $221M x 4.0x
Mira Pharmaceuticals, Inc. MIRA ██% $44M x 4.2x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.85B x 18.6x
Milestone Pharmaceuticals Inc. MIST ██% $216M x 5.2x
Moonlake Immunotherapeutics MLTX ██% $1.35B x 4.4x
Mineralys Therapeutics, Inc. MLYS ██% $2.23B x 3.4x
Mannkind Corp MNKD ██% $843M 143.9x x
Medicinova Inc MNOV ██% $69M x 1.7x
Monopar Therapeutics MNPR ██% $388M x 2.8x
Maplight Therapeutics, Inc. MPLT ██% $1.23B x 2.7x
Mereo Biopharma Group Plc MREO ██% $53M x 1.3x
Merck & Co., Inc. MRK ██% $300.14B 16.4x 5.7x
Marker Therapeutics, Inc. MRKR ██% $27M x 1.6x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.21B x 5.7x
Matinas Biopharma Holdings, Inc. MTNB ██% $3M x 0.7x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $8M x 1.4x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.94B x 5.8x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $469M 24.1x 2.9x
Novabridge Biosciences NBP ██% $294M x 1.1x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $44M x x
Newcelx Ltd. NCEL ██% $11M x 21.2x
Nucana Plc NCNA ██% $9M x x
Minerva Neurosciences, Inc. NERV ██% $254M x x
Neuphoria Therapeutics Inc. NEUP ██% $25M x 0.9x
Neurogene Inc. NGNE ██% $322M x 1.2x
Nika Pharmaceuticals, Inc NIKA ██% $785M x x
Nektar Therapeutics NKTR ██% $2.33B x 26.0x
Nkarta, Inc. NKTX ██% $163M x 0.5x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $22M x 2.0x
Nurix Therapeutics, Inc. NRIX ██% $1.69B x 3.5x
Neurosense Therapeutics Ltd. NRSN ██% $24M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $79M x x
Neonc Technologies Holdings, Inc. NTHI ██% $134M x x
Nuvation Bio Inc. NUVB ██% $1.64B x 5.4x
Nuvalent, Inc. NUVL ██% $7.63B x 6.1x
Nuvectis Pharma, Inc. NVCT ██% $224M x 12.2x
Novartis Ag NVS ██% $292.67B x x
Northwest Biotherapeutics Inc NWBO ██% $304M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $45M x 1.3x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.89B x 2.9x
Oragenics Inc OGEN ██% $3M x 0.3x
Organigram Global Inc. OGI ██% $197M x x
Organon & Co. OGN ██% $2.26B 12.1x 3.0x
Onkure Therapeutics, Inc. OKUR ██% $62M x 1.1x
Olema Pharmaceuticals, Inc. OLMA ██% $1.33B x 2.8x
Omeros Corp OMER ██% $849M x x
Beone Medicines Ltd. ONC ██% $35.61B 124.1x 8.2x
Onconetix, Inc. ONCO ██% $650K x 0.0x
Oncolytics Biotech Inc ONCY ██% $118M x x
Opko Health, Inc. OPK ██% $879M x 0.7x
Organogenesis Holdings Inc. ORGO ██% $319M 8.6x 1.1x
Orgenesis Inc. ORGS ██% $6M x x
Oric Pharmaceuticals, Inc. ORIC ██% $1.18B x 3.1x
Oruka Therapeutics, Inc. ORKA ██% $3.27B x 6.9x
Oramed Pharmaceuticals Inc. ORMP ██% $149M 2.3x 0.8x
Os Therapies Inc OSTX ██% $61M x x
Oncotelic Therapeutics, Inc. OTLC ██% $18M x 1.9x
Ovid Therapeutics Inc. OVID ██% $447M x 3.4x
One World Products, Inc. OWPC ██% $570K x x
Phibro Animal Health Corp PAHC ██% $2.39B 28.1x 7.2x
Prestige Consumer Healthcare Inc. PBH ██% $2.71B 14.6x 1.5x
Psyence Biomedical Ltd. PBM ██% $7M x x
Puma Biotechnology, Inc. PBYI ██% $382M 12.3x 2.9x
Pacira Biosciences, Inc. PCRX ██% $977M 138.8x 1.4x
Processa Pharmaceuticals, Inc. PCSA ██% $8M x 1.4x
Procyon Corp PCYN ██% $2M x 1.0x
Pds Biotechnology Corp PDSB ██% $58M x 6.3x
Pepgen Inc. PEPG ██% $116M x 0.8x
Pfizer Inc PFE ██% $154.07B 19.8x 1.8x
Precigen, Inc. PGEN ██% $1.41B x 67.4x
Phathom Pharmaceuticals, Inc. PHAT ██% $1.01B x x
Phio Pharmaceuticals Corp. PHIO ██% $15M x 0.7x
Pharvaris N.V. PHVS ██% $1.88B x x
Protokinetix, Inc. PKTX ██% $3M x 10.8x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $80M x 0.4x
Polomar Health Services, Inc. PMHS ██% $4M x 0.6x
Promis Neurosciences Inc. PMN ██% $108M x x
Pmv Pharmaceuticals, Inc. PMVP ██% $78M x 0.8x
Purple Biotech Ltd. PPBT ██% $6M x x
Propanc Biopharma, Inc. PPCB ██% $2M x 0.2x
Praxis Precision Medicines, Inc. PRAX ██% $8.66B x 9.9x
Prf Technologies Ltd. PRFX ██% $2M x 0.3x
Perrigo Co Plc PRGO ██% $1.58B x 0.5x
Prelude Therapeutics Inc PRLD ██% $277M x 4.0x
Prophase Labs, Inc. PRPH ██% $660K x 0.1x
Proqr Therapeutics N.V. PRQR ██% $210M x x
Prothena Corp Public Ltd Co PRTA ██% $571M x 2.0x
Ptc Therapeutics, Inc. PTCT ██% $5.95B 8.7x x
Protagonist Therapeutics, Inc PTGX ██% $6.55B x 10.7x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M x x
Palatin Technologies Inc PTN ██% $36M x 3.2x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $250K x 0.1x
Pulmatrix, Inc. PULM ██% $5M x 1.2x
Provectus Biopharmaceuticals, Inc. PVCT ██% $23M x x
Palvella Therapeutics, Inc. PVLA ██% $1.85B x 66.3x
Pyxis Oncology, Inc. PYXS ██% $107M x 2.0x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $11M x 0.9x
Quantum Biopharma Ltd. QNTM ██% $18M x x
Q32 Bio Inc. QTTB ██% $86M 2.9x 2.1x
Mainz Biomed N.V. QUCY ██% $8M x 11.8x
Uniqure N.V. QURE ██% $1.07B x 5.4x
Radiopharm Theranostics Ltd RADX ██% $36M x x
Rani Therapeutics Holdings, Inc. RANI ██% $83M x 2.5x
Rapport Therapeutics, Inc. RAPP ██% $1.73B x 3.6x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.37B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $394M x 1.4x
Arcus Biosciences, Inc. RCUS ██% $2.88B x 4.6x
Dr Reddys Laboratories Ltd RDY ██% $10.96B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $79.03B 17.5x 2.5x
Revelation Biosciences, Inc. REVB ██% $4M x 0.5x
Rafael Holdings, Inc. RFL ██% $62M x 0.8x
Regen Biopharma Inc RGBP ██% $130K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $575M 1.6x 1.5x
Relmada Therapeutics, Inc. RLMD ██% $754M x 8.7x
Rallybio Corp RLYB ██% $44M x 0.8x
Retrieve Medical Holdings, Inc. RMHI ██% $26M x x
Rockwell Medical, Inc. RMTI ██% $37M x 1.0x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $154M x x
Transcode Therapeutics, Inc. RNAZ ██% $7M x 5.2x
Rein Therapeutics, Inc. RNTX ██% $45M x 2.7x
Renovorx, Inc. RNXT ██% $49M x 9.0x
Roivant Sciences Ltd. ROIV ██% $20.55B x 4.8x
Royalty Pharma Plc RPRX ██% $28.94B 37.5x 4.5x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $11M x 1.3x
Rhythm Pharmaceuticals, Inc. RYTM ██% $5.83B x 42.0x
Rezolute, Inc. RZLT ██% $339M x 2.7x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $5M x 0.2x
Scienture Holdings, Inc. SCNX ██% $14M x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $44M x 0.9x
Schrodinger, Inc. SDGR ██% $875M x 2.4x
Septerna, Inc. SEPN ██% $1.08B x 2.8x
Serina Therapeutics, Inc. SER ██% $24M x x
Sagimet Biosciences Inc. SGMT ██% $175M x 1.6x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $4M x 1.8x
Siga Technologies Inc SIGA ██% $328M 14.1x 1.7x
Silo Pharma, Inc. SILO ██% $7M x 1.1x
Sionna Therapeutics, Inc. SION ██% $1.99B x 6.5x
Skinvisible, Inc. SKVI ██% $2M x x
Skye Bioscience, Inc. SKYE ██% $27M x 1.4x
Sol-Gel Technologies Ltd. SLGL ██% $241M x 10.6x
Silence Therapeutics Plc SLN ██% $284M x 4.6x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.75B 131.8x 6.1x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $855M x 12.1x
Summit Therapeutics Inc. SMMT ██% $16.86B x 25.6x
Semnur Pharmaceuticals, Inc. SMNR ██% $1.84B x x
Syndax Pharmaceuticals Inc SNDX ██% $2.16B x 33.4x
Soligenix, Inc. SNGX ██% $11M x 2.2x
Sibannac, Inc. SNNC ██% $1M x x
Sensei Biotherapeutics, Inc. SNSE ██% $40M x 2.2x
Sanofi SNY ██% $116.10B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $89M x 2.1x
Scisparc Ltd. SPRC ██% $2M x x
Spero Therapeutics, Inc. SPRO ██% $157M 18.3x 2.7x
Ars Pharmaceuticals, Inc. SPRY ██% $794M x 7.0x
Sarepta Therapeutics, Inc. SRPT ██% $2.28B x 2.0x
Stoke Therapeutics, Inc. STOK ██% $2.14B x 6.1x
Shattuck Labs, Inc. STTK ██% $512M x 6.2x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.90B x 2.7x
Savara Inc SVRA ██% $1.26B x 6.2x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $5M x 1.5x
Synlogic, Inc. SYBX ██% $7M x 0.6x
Spyre Therapeutics, Inc. SYRE ██% $4.93B x 6.9x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $56.71B x x
Theravance Biopharma, Inc. TBPH ██% $844M 8.0x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $7M x 3.3x
Telomir Pharmaceuticals, Inc. TELO ██% $44M x 7.5x
Tenax Therapeutics, Inc. TENX ██% $245M x 2.5x
Terns Pharmaceuticals, Inc. TERN ██% $5.92B x 5.9x
Teva Pharmaceutical Industries Ltd TEVA ██% $36.01B 25.5x 4.6x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $5.32B 11.9x 8.2x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $41M x 2.4x
Telix Pharmaceuticals Ltd TLX ██% $3.71B x x
Tango Therapeutics, Inc. TNGX ██% $3.31B x 9.6x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $183M x 0.7x
Theriva Biologics, Inc. TOVX ██% $11M x 0.7x
Tempest Therapeutics, Inc. TPST ██% $31M x 4.7x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $528M x 1.7x
Trevi Therapeutics, Inc. TRVI ██% $1.74B x 9.5x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $100M x 21.2x
Tvardi Therapeutics, Inc. TVRD ██% $29M x 1.4x
Travere Therapeutics, Inc. TVTX ██% $3.76B x 32.7x
Therapeuticsmd, Inc. TXMD ██% $25M x 0.9x
Tyra Biosciences, Inc. TYRA ██% $1.93B x 7.5x
Unicycive Therapeutics, Inc. UNCY ██% $172M x 5.7x
Upstream Bio, Inc. UPB ██% $560M x 1.7x
Urogen Pharma Ltd. URGN ██% $1.03B x x
United Therapeutics Corp UTHR ██% $25.30B 19.0x 3.6x
Vaccinex, Inc. VCNX ██% $4M x x
Vera Therapeutics, Inc. VERA ██% $3.27B x 5.4x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Vg Life Sciences Inc. VGLS ██% $4M x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $4.14B x 6.5x
Vanda Pharmaceuticals Inc. VNDA ██% $432M x 1.3x
Verrica Pharmaceuticals Inc. VRCA ██% $100M x 4.0x
Viridian Therapeutics, Inc.\De VRDN ██% $1.54B x 2.1x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $112.00B 28.3x 6.0x
Verastem, Inc. VSTM ██% $533M x 9.3x
Vistagen Therapeutics, Inc. VTGN ██% $25M x 0.5x
Viatris Inc VTRS ██% $16.29B x 1.1x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $20M x 0.7x
Whitehawk Therapeutics, Inc. WHWK ██% $173M x 1.3x
Wave Life Sciences Ltd. WVE ██% $1.39B x 2.7x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $74M x 0.5x
Exicure, Inc. XCUR ██% $25M x 6.3x
Xenon Pharmaceuticals Inc. XENE ██% $5.71B x 9.8x
Xeris Biopharma Holdings, Inc. XERS ██% $1.02B 1837.7x 74.4x
Xilio Therapeutics, Inc. XLO ██% $50M x 1.4x
Xencor Inc XNCR ██% $903M x 1.4x
Xoma Royalty Corp XOMA ██% $470M 14.8x 5.6x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.33B x 5.5x
Zai Lab Ltd ZLAB ██% $2.50B x 3.5x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $365M x 1.7x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $51.51B 19.3x 15.5x
Zevra Therapeutics, Inc. ZVRA ██% $555M 6.7x 3.6x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - An2 Therapeutics, Inc. Stock Forecast

How accurate are An2 Therapeutics, Inc. stock predictions?

Our AI model shows a 8% Spearman correlation coefficient for ANTX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence An2 Therapeutics, Inc. stock price forecasts?

Our analysis considers An2 Therapeutics, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is An2 Therapeutics, Inc. a good investment in 2025?

Based on our AI analysis, An2 Therapeutics, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are An2 Therapeutics, Inc. forecasts updated?

An2 Therapeutics, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of An2 Therapeutics, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...